Odorant Receptor Proteins in the Mouse Main Olfactory Epithelium and Olfactory Bulb

Total Page:16

File Type:pdf, Size:1020Kb

Odorant Receptor Proteins in the Mouse Main Olfactory Epithelium and Olfactory Bulb NSC 17525 No. of Pages 11 7 January 2017 Please cite this article in press as: Low VF, Mombaerts P. Odorant receptor proteins in the mouse main olfactory epithelium and olfactory bulb. Neu- roscience (2017), http://dx.doi.org/10.1016/j.neuroscience.2016.12.044 1 Neuroscience xxx (2017) xxx–xxx 2 ODORANT RECEPTOR PROTEINS IN THE MOUSE MAIN OLFACTORY 3 EPITHELIUM AND OLFACTORY BULB 4 VICTORIA F. LOW AND PETER MOMBAERTS * INTRODUCTION 9 5 Max Planck Research Unit for Neurogenetics, In mammals such as mouse and rat, odorants are 10 6 Max-von-Laue-Strasse 4, D-60438 Frankfurt, Germany detected in the main olfactory epithelium (MOE) by 11 olfactory sensory neurons (OSNs) via odorant receptors 12 7 Abstract—In the mouse, odorant receptor proteins (ORs) are (ORs), which are G-protein-coupled seven- 13 G-protein-coupled receptors expressed in mature olfactory transmembrane proteins (Buck and Axel, 1991). In the 14 sensory neurons (OSNs) of the main olfactory epithelium mouse, there are 1099 OR genes with an intact open 15 (MOE). ORs mediate odorant reception at the level of the reading frame, of which 1,087 are expressed at the 16 OSN cilia. Most 1100 OR genes in the mouse genome are RNA level in OSNs (Saraiva et al., 2015). 17 expressed, at the RNA level, in mature OSNs. The literature Due to the difficulty in raising antibodies against 18 on antibodies against ORs is limited, and most reports are with antibodies that are not commercially available. Here G-protein-coupled receptors, there have been relatively 19 we have screened 40 commercial antibodies against human few reports about OR proteins in the literature. Initial 20 and mouse ORs by immunofluorescence staining of coronal studies with antibodies against rat ORs suggested that 21 cryosections of the MOE of 21-day-old C57BL/6J mice. the antigen is localized to the cilia of OSNs in the rat 22 Various methods of antigen retrieval were tested. Of the 19 MOE (Koshimoto et al., 1992; Krieger et al., 1994). In situ 23 antibodies raised against human ORs, three yielded a con- hybridization against OR RNAs in mouse revealed that 24 sistent immunoreactive signal in the mouse MOE; of these OR gene expression is restricted to OSNs within discrete 25 three, two appeared to cross react against one or more, regions of the MOE called zones (Ressler et al., 1993; 26 unknown, mouse ORs. Of the 21 antibodies raised against Miyamichi et al., 2005). Gene-targeted mice enabled the 27 mouse ORs, six yielded a consistent immunoreactive signal visualization of entire OSNs expressing a given OR by 28 in the mouse MOE; of these six, two also stained specific glomeruli in the olfactory bulb. Antibody specificity could targeted integration of a cassette that affords cotransla- 29 be validated with gene-targeted mouse strains in the case tion of the OR with a marker such as taulacZ via an inter- 30 of three ORs. The number of OSNs immunoreactive for the nal ribosome entry site (IRES) (Mombaerts et al., 1996). 31 MOR28/Olfr1507 antibody is greater in C57BL/6J than in Axons of OSNs expressing the same OR coalesce into 32 129S6/SvEvTac wild-type mice. Taken together, our results two or a few glomeruli per mouse olfactory bulb, which 33 are encouraging: 20–30% of these commercially available reside in highly restricted regions (Ressler et al., 1994; 34 antibodies are informative in immunohistochemical analy- Mombaerts et al., 1996; Zapiec and Mombaerts, 2015). 35 ses of the mouse MOE. The commercial availability of these Replacement of the OR coding region showed that the 36 antibodies should facilitate the study of OR proteins in the OR does not only mediate odorant detection (Bozza 37 MOE and the olfactory bulb, and the replicability of results et al., 2002), but is also a determinant of where in the 38 in the literature. Ó 2016 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article under olfactory bulb the axons coalesce and form glomeruli 39 the CC BY-NC-ND license (http://creativecommons.org/ (Mombaerts et al., 1996; Feinstein et al., 2004; Feinstein 40 licenses/by-nc-nd/4.0/). and Mombaerts, 2004). 41 The widespread success of the gene-targeted 42 approach of the OR-IRES-marker design may have 43 Key words: olfactory receptor, olfactory sensory neuron, overshadowed or diminished efforts to raise and 44 glomerulus, antibody, immunofluorescence, antigen retrieval. characterize OR antibodies. But these gene-targeted 45 8 mutations are designed to visualize the OSNs (including 46 their cilia, dendrite, cell body, axon, and axon terminals) 47 that express a given OR, and do not enable the 48 visualization of the subcellular localization of the OR 49 protein within the OSNs. An attempt at creating an OR: 50 *Corresponding author. GFP C-terminal fusion protein by gene targeting 51 E-mail addresses: [email protected] (V. F. Low), peter.mom- resulted, for reasons that remain unclear, in altered 52 [email protected] (P. Mombaerts). Abbreviations: aa, amino acid; AR, antigen retrieval; EDTA, positions of the corresponding glomeruli in the olfactory 53 ethylenediaminetetraacetic acid; GFP, green fluorescent protein; bulb (Feinstein et al., 2004). 54 IRES, internal ribosome entry site; MOE, main olfactory epithelium; Antibodies against mouse ORs revealed that OR 55 OMP, olfactory marker protein; OR, odorant receptor; OSN, olfactory 56 sensory neuron; PBS, phosphate-buffered saline; PFA, proteins are present not only in OSN cilia, dendrite, and paraformaldehyde; SDS, sodium dodecyl sulfate. cell body but also within the axon and axon terminals 57 http://dx.doi.org/10.1016/j.neuroscience.2016.12.044 0306-4522/Ó 2016 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1 NSC 17525 No. of Pages 11 7 January 2017 2 V. F. Low, P. Mombaerts / Neuroscience xxx (2017) xxx–xxx 58 (Barnea et al., 2004; Strotmann et al., 2004), thus sup- 5 mg/kg body weight, respectively) and perfused with 115 59 porting the notion that the OR protein is involved in axonal 5 ml ice-cold phosphate-buffered saline (PBS), followed 116 60 wiring of OSNs. by 15 ml 2% paraformaldehyde in PBS (PFA). The 117 61 A quarter of a century after the discovery of mouse heads were dissected, postfixed in 2% PFA for 118 62 mammalian OR genes (Buck and Axel, 1991), there are 2 h at 4 °C, and decalcified in 0.45 M EDTA in PBS 119 63 still few papers on immunofluorescence staining of the overnight at 4 °C. Samples were cryoprotected in, 120 64 mouse MOE and olfactory bulb with OR antibodies that successively, 15% and 30% sucrose in PBS at 4 °C, 121 65 are commercially available. There are numerous antibod- frozen in O.C.T. Compound (Tissue-Tek), sectioned at 122 66 ies against ORs on the market, but they remain largely 12 lm with a Leica CM3500 cryostat, and collected onto 123 67 uncharacterized. The signal yielded by such antibodies glass slides. Alternative fixation methods were also 124 68 can be affected by the high sequence homology between tested; perfusion with 4% PFA resulted in poorer 125 69 ORs, by post-translational modifications, by protein fold- antigenicity, and immersion fixation in 2% PFA for 2 h 126 70 ing, by protein–protein interactions, and by fixation without perfusion did not yield improved antigenicity. 127 71 crosslinking. To increase the accessibility of the antigen 72 to the antibody, antigen retrieval can be used to break Antigen retrieval. Various antigen retrieval steps were 128 73 some of the crosslinks formed during fixation and to alter tested to optimize visualization of the target protein. 129 74 the protein re-folding following heat denaturation (Shi These included a 10-min incubation in 2 M HCl at room 130 75 et al., 2001; Emoto, 2005). Epitope unmasking through temperature, or 10 min in ice-cold 100% methanol 131 76 antigen retrieval can allow for a more accurate detection, followed by 0.5% sodium dodecyl sulfate (SDS) in PBS 132 77 and therefore representation, of the antigen. at room temperature. Antigen retrieval with a pressure 133 78 Here, we describe our screening of 40 commercially cooker (2100 Retriever; BioVendor) was carried out with 134 79 available antibodies against human and mouse ORs in 10 mM citric acid pH 6.0 and 10 mM Tris pH 9.0 with or 135 80 the mouse MOE using various antigen retrieval without 0.05% Tween 20 and 2 mM EDTA. After heating 136 81 techniques, in coronal 12-lm sections of the MOE of in a pressure cooker to 121 °C, slides were left to cool 137 82 21- day-old C57BL/6J mice. We obtained reliable for 2 h in the retrieval buffer. Additionally, PBS washes 138 83 immunoreactive signals with two antibodies against were tested with 0.05% Tween 20 or 0.2% Triton X-100, 139 84 human ORs (due to presumed crossreactivity with and incubation with antibody was tested for various 140 85 mouse ORs) and six antibodies against mouse ORs in times during a period of 1–4 days, with and without 141 86 the mouse MOE. Of these six, two antibodies also 0.1% Triton X-100. Best results were obtained with PBS 142 87 stained specific glomeruli in the olfactory bulb. washes and incubation with antibody diluted with 0.1% 143 Triton X-100. There was no obvious difference in 144 88 EXPERIMENTAL PROCEDURES antigen detection with different incubation times.
Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
    [Show full text]
  • A. Cellular Senescence
    Generation of antisense RNAs at convergent gene loci in cells undergoing senescence Maharshi Krishna Deb To cite this version: Maharshi Krishna Deb. Generation of antisense RNAs at convergent gene loci in cells undergo- ing senescence. Human genetics. Université Paul Sabatier - Toulouse III, 2016. English. NNT : 2016TOU30274. tel-03209213 HAL Id: tel-03209213 https://tel.archives-ouvertes.fr/tel-03209213 Submitted on 27 Apr 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 5)µ4& &OWVFEFMPCUFOUJPOEV %0$503"5%&-6/*7&34*5²%&506-064& %ÏMJWSÏQBS Université Toulouse 3 Paul Sabatier (UT3 Paul Sabatier) 1SÏTFOUÏFFUTPVUFOVFQBS DEB Maharshi Krishna -F mercredi 30 mars 2016 5Jtre : Generation of antisense RNAs at convergent gene loci in cells undergoing senescence École doctorale et discipline ou spécialité : ED BSB : Génétique moléculaire 6OJUÏEFSFDIFSDIF CNRS-UMR5088; LBCMCP %JSFDUFVS T EFʾÒTF Dr. TROUCHE Didier Co-Directeur/trice(s) de Thèse : Dr. NICOLAS Estelle 3BQQPSUFVST Prof. GILSON Eric, Dr. LIBRI Domenico, Dr. VERDEL Andre "VUSF T NFNCSF T EVKVSZ Prof. GLEIZES Pierre Emmanuel, President of Jury Dr. TROUCHE Didier, Thesis Supervisor This thesis is dedicated to any patients who may get cured with treatments manifesting from this work.
    [Show full text]
  • Misexpression of Cancer/Testis (Ct) Genes in Tumor Cells and the Potential Role of Dream Complex and the Retinoblastoma Protein Rb in Soma-To-Germline Transformation
    Michigan Technological University Digital Commons @ Michigan Tech Dissertations, Master's Theses and Master's Reports 2019 MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION SABHA M. ALHEWAT Michigan Technological University, [email protected] Copyright 2019 SABHA M. ALHEWAT Recommended Citation ALHEWAT, SABHA M., "MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO- GERMLINE TRANSFORMATION", Open Access Master's Thesis, Michigan Technological University, 2019. https://doi.org/10.37099/mtu.dc.etdr/933 Follow this and additional works at: https://digitalcommons.mtu.edu/etdr Part of the Cancer Biology Commons, and the Cell Biology Commons MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION By Sabha Salem Alhewati A THESIS Submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE In Biological Sciences MICHIGAN TECHNOLOGICAL UNIVERSITY 2019 © 2019 Sabha Alhewati This thesis has been approved in partial fulfillment of the requirements for the Degree of MASTER OF SCIENCE in Biological Sciences. Department of Biological Sciences Thesis Advisor: Paul Goetsch. Committee Member: Ebenezer Tumban. Committee Member: Zhiying Shan. Department Chair: Chandrashekhar Joshi. Table of Contents List of figures .......................................................................................................................v
    [Show full text]
  • The Potential Druggability of Chemosensory G Protein-Coupled Receptors
    International Journal of Molecular Sciences Review Beyond the Flavour: The Potential Druggability of Chemosensory G Protein-Coupled Receptors Antonella Di Pizio * , Maik Behrens and Dietmar Krautwurst Leibniz-Institute for Food Systems Biology at the Technical University of Munich, Freising, 85354, Germany; [email protected] (M.B.); [email protected] (D.K.) * Correspondence: [email protected]; Tel.: +49-8161-71-2904; Fax: +49-8161-71-2970 Received: 13 February 2019; Accepted: 12 March 2019; Published: 20 March 2019 Abstract: G protein-coupled receptors (GPCRs) belong to the largest class of drug targets. Approximately half of the members of the human GPCR superfamily are chemosensory receptors, including odorant receptors (ORs), trace amine-associated receptors (TAARs), bitter taste receptors (TAS2Rs), sweet and umami taste receptors (TAS1Rs). Interestingly, these chemosensory GPCRs (csGPCRs) are expressed in several tissues of the body where they are supposed to play a role in biological functions other than chemosensation. Despite their abundance and physiological/pathological relevance, the druggability of csGPCRs has been suggested but not fully characterized. Here, we aim to explore the potential of targeting csGPCRs to treat diseases by reviewing the current knowledge of csGPCRs expressed throughout the body and by analysing the chemical space and the drug-likeness of flavour molecules. Keywords: smell; taste; flavour molecules; drugs; chemosensory receptors; ecnomotopic expression 1. Introduction Thirty-five percent of approved drugs act by modulating G protein-coupled receptors (GPCRs) [1,2]. GPCRs, also named 7-transmembrane (7TM) receptors, based on their canonical structure, are the largest family of membrane receptors in the human genome.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • WO 2019/068007 Al Figure 2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/068007 Al 04 April 2019 (04.04.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors; and C12N 15/10 (2006.01) C07K 16/28 (2006.01) (71) Applicants: GROSS, Gideon [EVIL]; IE-1-5 Address C12N 5/10 (2006.0 1) C12Q 1/6809 (20 18.0 1) M.P. Korazim, 1292200 Moshav Almagor (IL). GIBSON, C07K 14/705 (2006.01) A61P 35/00 (2006.01) Will [US/US]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., C07K 14/725 (2006.01) P.O. Box 4044, 7403635 Ness Ziona (TL). DAHARY, Dvir [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (21) International Application Number: Box 4044, 7403635 Ness Ziona (IL). BEIMAN, Merav PCT/US2018/053583 [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (22) International Filing Date: Box 4044, 7403635 Ness Ziona (E.). 28 September 2018 (28.09.2018) (74) Agent: MACDOUGALL, Christina, A. et al; Morgan, (25) Filing Language: English Lewis & Bockius LLP, One Market, Spear Tower, SanFran- cisco, CA 94105 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 62/564,454 28 September 2017 (28.09.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/649,429 28 March 2018 (28.03.2018) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (71) Applicant: IMMP ACT-BIO LTD.
    [Show full text]
  • Predicting Human Olfactory Perception from Activities of Odorant Receptors
    iScience ll OPEN ACCESS Article Predicting Human Olfactory Perception from Activities of Odorant Receptors Joel Kowalewski, Anandasankar Ray [email protected] odor perception HIGHLIGHTS Machine learning predicted activity of 34 human ORs for ~0.5 million chemicals chemical structure Activities of human ORs predicts OR activity could predict odor character using machine learning Few OR activities were needed to optimize r predictions of each odor e t c percept a AI r a odorant activates mul- h Behavior predictions in c Drosophila also need few r tiple ORs o olfactory receptor d o activities ts ic ed pr ity tiv ac OR Kowalewski & Ray, iScience 23, 101361 August 21, 2020 ª 2020 The Author(s). https://doi.org/10.1016/ j.isci.2020.101361 iScience ll OPEN ACCESS Article Predicting Human Olfactory Perception from Activities of Odorant Receptors Joel Kowalewski1 and Anandasankar Ray1,2,3,* SUMMARY Odor perception in humans is initiated by activation of odorant receptors (ORs) in the nose. However, the ORs linked to specific olfactory percepts are unknown, unlike in vision or taste where receptors are linked to perception of different colors and tastes. The large family of ORs (~400) and multiple receptors activated by an odorant present serious challenges. Here, we first use machine learning to screen ~0.5 million compounds for new ligands and identify enriched structural motifs for ligands of 34 human ORs. We next demonstrate that the activity of ORs successfully predicts many of the 146 different perceptual qualities of chem- icals. Although chemical features have been used to model odor percepts, we show that biologically relevant OR activity is often superior.
    [Show full text]
  • Genetic Characterization of Greek Population Isolates Reveals Strong Genetic Drift at Missense and Trait-Associated Variants
    ARTICLE Received 22 Apr 2014 | Accepted 22 Sep 2014 | Published 6 Nov 2014 DOI: 10.1038/ncomms6345 OPEN Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variants Kalliope Panoutsopoulou1,*, Konstantinos Hatzikotoulas1,*, Dionysia Kiara Xifara2,3, Vincenza Colonna4, Aliki-Eleni Farmaki5, Graham R.S. Ritchie1,6, Lorraine Southam1,2, Arthur Gilly1, Ioanna Tachmazidou1, Segun Fatumo1,7,8, Angela Matchan1, Nigel W. Rayner1,2,9, Ioanna Ntalla5,10, Massimo Mezzavilla1,11, Yuan Chen1, Chrysoula Kiagiadaki12, Eleni Zengini13,14, Vasiliki Mamakou13,15, Antonis Athanasiadis16, Margarita Giannakopoulou17, Vassiliki-Eirini Kariakli5, Rebecca N. Nsubuga18, Alex Karabarinde18, Manjinder Sandhu1,8, Gil McVean2, Chris Tyler-Smith1, Emmanouil Tsafantakis12, Maria Karaleftheri16, Yali Xue1, George Dedoussis5 & Eleftheria Zeggini1 Isolated populations are emerging as a powerful study design in the search for low-frequency and rare variant associations with complex phenotypes. Here we genotype 2,296 samples from two isolated Greek populations, the Pomak villages (HELIC-Pomak) in the North of Greece and the Mylopotamos villages (HELIC-MANOLIS) in Crete. We compare their genomic characteristics to the general Greek population and establish them as genetic isolates. In the MANOLIS cohort, we observe an enrichment of missense variants among the variants that have drifted up in frequency by more than fivefold. In the Pomak cohort, we find novel associations at variants on chr11p15.4 showing large allele frequency increases (from 0.2% in the general Greek population to 4.6% in the isolate) with haematological traits, for example, with mean corpuscular volume (rs7116019, P ¼ 2.3 Â 10 À 26). We replicate this association in a second set of Pomak samples (combined P ¼ 2.0 Â 10 À 36).
    [Show full text]
  • Functional and Structural Characterization of Olfactory Receptors in Human Heart and Eye
    DISSERTATION to obtain the degree Doctor Rerum Naturalium (Dr.rer.nat.) at the Faculty of Biology and Biotechnology International Graduate School Biosciences Ruhr-University Bochum Functional and structural characterization of olfactory receptors in human heart and eye Department of Cellphysiology submitted by Nikolina Jovancevic from Zadar, Croatia Bochum February 2016 First Referee: Prof. Dr. Dr. Dr. Hanns Hatt Second Referee: Prof. Dr. Stefan Wiese DISSERTATION zur Erlangung des Grades eines Doktors der Naturwissenschaften der Fakultät für Biologie und Biotechnologie an der Internationalen Graduiertenschule Biowissenschaften der Ruhr-Universität Bochum Funktionale und strukturelle Charakterisierung olfaktorischer Rezeptoren im humanen Herzen und Auge Lehrstuhl für Zellphysiologie vorgelegt von Nikolina Jovancevic aus Zadar, Kroatien Bochum Februar 2016 Referent: Prof. Dr. Dr. Dr. Hanns Hatt Korreferent: Prof. Dr. Stefan Wiese To my family TABLE OF CONTENTS TABEL OF CONTENT 1 INTRODUCTION 1 1.1 G protein-coupled receptors 1 1.1.1 General 1 1.1.2 Structure and classification 2 1.1.3 Olfactory Receptors 4 1.2 Function of olfactory receptors 9 1.2.1 The olfactory system 9 1.2.2 Ectopic expression of olfactory receptors 11 1.3 Excursus: Anatomy and physiology of the heart 13 1.3.1 Anatomy of the heart and blood circuit 14 1.3.2 The cardiac conduction system 15 1.3.3 Excitation-contraction coupling 16 1.3.4 Cardiac GPCRs: Modulation of cardiac contraction 17 1.4 Excursus: Anatomy and physiology of the eye 18 1.4.1 Anatomy of the retina 19
    [Show full text]
  • 1 Novel Expression Signatures Identified by Transcriptional Analysis
    ARD Online First, published on October 7, 2009 as 10.1136/ard.2009.108043 Ann Rheum Dis: first published as 10.1136/ard.2009.108043 on 7 October 2009. Downloaded from Novel expression signatures identified by transcriptional analysis of separated leukocyte subsets in SLE and vasculitis 1Paul A Lyons, 1Eoin F McKinney, 1Tim F Rayner, 1Alexander Hatton, 1Hayley B Woffendin, 1Maria Koukoulaki, 2Thomas C Freeman, 1David RW Jayne, 1Afzal N Chaudhry, and 1Kenneth GC Smith. 1Cambridge Institute for Medical Research and Department of Medicine, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, UK 2Roslin Institute, University of Edinburgh, Roslin, Midlothian, EH25 9PS, UK Correspondence should be addressed to Dr Paul Lyons or Prof Kenneth Smith, Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, UK. Telephone: +44 1223 762642, Fax: +44 1223 762640, E-mail: [email protected] or [email protected] Key words: Gene expression, autoimmune disease, SLE, vasculitis Word count: 2,906 The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in Annals of the Rheumatic Diseases and any other BMJPGL products to exploit all subsidiary rights, as set out in their licence (http://ard.bmj.com/ifora/licence.pdf). http://ard.bmj.com/ on September 29, 2021 by guest. Protected copyright. 1 Copyright Article author (or their employer) 2009.
    [Show full text]
  • Genome-Wide Profiling of Druggable Active Tumor Defense Mechanisms to Enhance Cancer Immunotherapy
    bioRxiv preprint doi: https://doi.org/10.1101/843185; this version posted November 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy Rigel J. Kishton1,2,*,#, Shashank J. Patel1,2,†,*, Suman K. Vodnala1,2, Amy E. Decker3, Yogin Patel1,2, Madhusudhanan Sukumar1,2, Tori N. Yamamoto1,2,4, Zhiya Yu1,2, Michelle Ji1,2, Amanda N. Henning1,2, Devikala Gurusamy1,2, Douglas C. Palmer1,2, Winifred Lo1, Anna Pasetto1, Parisa Malekzadeh1, Drew C. Deniger1, Kris C. Wood3, Neville E. Sanjana5,6, Nicholas P. Restifo1,2, #, § 1Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA 2Center for Cell-Based Therapy, National Cancer Institute, Bethesda, MD 20892, USA 3Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA 4Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA 5New York Genome Center, New York, NY 10013 USA 6Department of Biology, New York University, New York, NY 10003, USA *These authors contributed equally to this work. †Present address: NextCure Inc., Beltsville, MD 20705, USA §Present address: Lyell Immunopharma, South San Francisco, CA 94080, USA #Corresponding authors. NPR: [email protected]. RJK: [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/843185; this version posted November 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Human Olfactory Receptors
    Human Olfactory Receptors: A journey from cell engineering for efficient in vitro functional assays to effective antagonists in human sensory assay Huysseune Sandra, Philippeau Magali, Moreau Cédric, Veithen Alex, Chatelain Pierre, Quesnel Yannick. ChemCom S.A., Route de Lennik 802, 1070 Anderlecht, Belgium. Cell lines Introduction: ChemCom's Entry ORs Literature data HEK293T HANA3 proprietary Many odorant compounds are perceived as unpleasant. They can be present in different contexts such as body-, home-, factory-, material-, or fabric-emitted 1 OR56A1 Adipietro et al., 2012 odors, so that humans are daily exposed to this olfactory pollution. In addition, odorant compounds can also taint food or beverages. Malodor and off-note 2 OR10J5 Saito et al., 2009 counteraction is a daily challenge for many different industries. 3 ORX116 - The first step of the odor perception corresponds to the interaction of olfactory receptors (ORs) with odorant molecules. Therefore, a selective inhibition of the 4 ORX069 - ORs by weakly odorant or odorless antagonists represents an innovative solution to malodor issues. The identification of such odor blockers requires an 5 OR10H5 - efficient technological platform to first fish out the receptors that interact with a malodor of interest and second, to screen libraries of potential antagonists of 6 OR8B3 Mainland et al., 2013 7 OR6P1 Mainland et al., 2013 these ORs. 8 ORX074B - 9 ORX126 - Materials and Methods: 10 ORX189 - 11 ORX081 - In vitro functional assay 12 ORX213 - Dilution-response analysis were performed in HEK293T, HANA3 and HEK293T-hRTP1S/hRTP2 cells using the CRE-luciferase reporter assay system. Briefly, each 13 OR1D2 Spehr et al., 2003 cell plated one day before was transfected with deorphanized ORs (identified at Chemcom S.A.) or empty vector plasmids using TransIT®-LT1 (Mirus) 14 OR7C1 Mainland et al., 2013 according to the manufacturer’s protocol.
    [Show full text]